New trials show promise for immune checkpoint blockers in early-stage lung cancer

FHS
April 18, 2024
12:23 pm

A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).

Innovaccer Launches AI Automation Suite, Sara for Healthcare

What You Should Know: Innovaccer Inc., a data platform accelerating innovation in healthcare announced the launch of its new suite of AI solutions at the Innovation

August 23, 2023

Eli Lilly’s Prevail strikes potential billion-dollar AAV capsids deal with Sangamo for neurological diseases

Eli Lilly’s Prevail Therapeutics has expanded again into neurological targets thanks to a potential billion-dollar deal with Sangamo Therapeutics. The pair will evaluate some of

July 18, 2023

Health Canada approves GSK’s RSV vaccine for older individuals

GSK’s Arexvy is the first respiratory syncytial virus vaccine for older adults approved in Canada. Credit: CNW Group/GlaxoSmithKline Inc. Health Canada has granted approval for GSK’s Arexvy

August 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.